APA (7. basım) Alıntı

Guièze, R., Robbe, P., Clifford, R., de Guibert, S., Pereira, B., Timbs, A., . . . Schuh, A. (2015). Presence of multiple recurrent mutations confers poor trial outcome of relapsed/refractory CLL. American Society of Hematology.

Chicago Style (17. basım) Atıf

Guièze, R., et al. Presence of Multiple Recurrent Mutations Confers Poor Trial Outcome of Relapsed/refractory CLL. American Society of Hematology, 2015.

MLA (9th ed.) Atıf

Guièze, R., et al. Presence of Multiple Recurrent Mutations Confers Poor Trial Outcome of Relapsed/refractory CLL. American Society of Hematology, 2015.